Sharrow Allison C, Ishihara Moe, Hu Junhui, Kim Il Hyun, Wu Lily
Molecular and Medical Pharmacology, University of California Los Angeles;
Molecular and Medical Pharmacology, University of California Los Angeles.
J Vis Exp. 2020 Jan 28(155). doi: 10.3791/60651.
Mouse models are the benchmark tests for in vivo cancer studies. However, cost, time, and ethical considerations have led to calls for alternative in vivo cancer models. The chicken chorioallantoic membrane (CAM) model provides an inexpensive, rapid alternative that permits direct visualization of tumor development and is suitable for in vivo imaging. As such, we sought to develop an optimized protocol for engrafting gynecological and urological tumors into this model, which we present here. Approximately 7 days postfertilization, the air cell is moved to the vascularized side of the egg, where an opening is created in the shell. Tumors from murine and human cell lines and primary tissues can then be engrafted. These are typically seeded in a mixture of extracellular matrix and medium to avoid cellular dispersal and provide nutrient support until the cells recruit a vascular supply. Tumors may then grow for up to an additional 14 days prior to the eggs hatching. By implanting cells stably transduced with firefly luciferase, bioluminescence imaging can be used for the sensitive detection of tumor growth on the membrane and cancer cell spread throughout the embryo. This model can potentially be used to study tumorigenicity, invasion, metastasis, and therapeutic effectiveness. The chicken CAM model requires significantly less time and financial resources compared to traditional murine models. Because the eggs are immunocompromised and immune tolerant, tissues from any organism can potentially be implanted without costly transgenic animals (e.g., mice) required for implantation of human tissues. However, many of the advantages of this model could potentially also be limitations, including the short tumor generation time and immunocompromised/immune tolerant status. Additionally, although all tumor types presented here engraft in the chicken chorioallantoic membrane model, they do so with varying degrees of tumor growth.
小鼠模型是体内癌症研究的基准测试。然而,成本、时间和伦理考量促使人们呼吁采用替代的体内癌症模型。鸡胚绒毛尿囊膜(CAM)模型提供了一种廉价、快速的替代方案,可直接观察肿瘤发展,适用于体内成像。因此,我们试图开发一种优化方案,将妇科和泌尿科肿瘤植入该模型,我们在此展示该方案。受精后约7天,将气室移至鸡蛋的血管化一侧,在蛋壳上开口。然后可以植入来自小鼠和人类细胞系以及原代组织的肿瘤。这些肿瘤通常接种在细胞外基质和培养基的混合物中,以避免细胞扩散,并在细胞募集血管供应之前提供营养支持。在鸡蛋孵化前,肿瘤可能会再生长14天。通过植入稳定转导萤火虫荧光素酶的细胞,生物发光成像可用于灵敏检测膜上肿瘤生长以及癌细胞在整个胚胎中的扩散。该模型可潜在用于研究肿瘤发生、侵袭、转移和治疗效果。与传统小鼠模型相比,鸡CAM模型所需的时间和财力资源要少得多。由于鸡蛋免疫功能低下且具有免疫耐受性,任何生物体的组织都有可能植入,无需用于植入人类组织的昂贵转基因动物(如小鼠)。然而,该模型的许多优点也可能是局限性,包括肿瘤生成时间短以及免疫功能低下/免疫耐受状态。此外,尽管这里展示的所有肿瘤类型都能植入鸡胚绒毛尿囊膜模型,但它们的肿瘤生长程度各不相同。